서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 19 of 19

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2002-11	A phase III randomized trial of 5-fluorouracil, doxorubicin, and mitomycin C versus 5-fluorouracil and mitomycin C versus 5-fluorouracil alone in curatively resected gastric cancer Chang, HM; Jung, KH; Kim, TY; Kim, WS; Yang, HK; Lee, KU; Choe, KJ; Heo, DS; Bang, YJ; Kim, NK Annals of Oncology, Vol.13 No.11, pp.1779-1785	DOI
2003-06	Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells Kim, Tai Young; Jong, Hyun-Soon; Song, Sang-Hyun; Dimtchev, Alexandre; Jeong, Sook-Jung; Lee, Jung Weon; Kim, Tae-You; Kim, Noe Kyeong; Jung, Mira; Bang, Yung-Jue Oncogene, Vol.22 No.25, pp.3943-3951	DOI
2004-04	Aberrant methylation of integrin α4 gene in human gastric cancer cells Park, Jinah; Song, Sang-Hyun; Kim, Tai Young; Choi, Moon-Chang; Jong, Hyun-Soon; Kim, Tae-You; Lee, Jung Weon; Kim, Noe Kyeong; Kim, Woo-Ho; Bang, Yung-Jue Oncogene, Vol.23 No.19, pp.3474-3480	DOI
2005-07	Docetaxel+5-fluorouracil plus cisplatin 3-day combination chemotherapy as a first-line treatment in patient with unresectable gastric cancer Oh, Do-Youn; Kim, Tae-Yong; Kwon, Jung Hye; Lee, Jae-Jin; Joh, Yohan; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.7, pp.380-385	DOI
2005-12	Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer Lee, Keun-Wook; Im, Seock Ah; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hyunchoon; Choi, In Sil; Oh, Do Youn; Kim, Jee Hyun; Kim, Dong Wan; Kim, Tae You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.12, pp.720-726	DOI
2007-09	Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer Lee, Keun-Wook; Kim, Jee Hyun; Yun, Tak; Song, Eun Kee; Na, Im Il; Shin, Hytinchoon; Oh, So Yeon; Choi, In Sil; Oh, Do-Youn; Kim, Dong-Wan; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Journal of Korean Medical Science, Vol.22, pp.S115-S121	view file
2008-02	Gene silencing of TSPYL5 mediated by aberrant promoter methylation in gastric cancers Jung, Yeonjoo; Park, Jinah; Bang, Yung-Jue; Kim, Tae-You Laboratory Investigation, Vol.88 No.2, pp.153-160	DOI
2008-02	Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer Kim, Yu Jung; Kim, Min A.; Im, Seock-Ah; Kim, Tae Min; Kim, Dong-Wan; Yang, Han-Kwang; Heo, Dae Seog; Lee, Kuhn-Uk; Choe, Kuk Jin; Kim, Noe Kyeong; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Cancer Investigation, Vol.26 No.2, pp.152-158	DOI
2008-09	Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer Seo, Myung-Deok; Lee, Keun-Wook; Lim, Joo Han; Yi, Hyeon Gyu; Kim, Dae-Young; Oh, Do-Youn; Kim, Jee Hyun; Im, Seock-Ah; Kim, Tae-You; Lee, Jong Seok; Bang, Yung-Jue Japanese Journal of Clinical Oncology, Vol.38 No.9, pp.589-595	DOI
2009-01	Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer Han, S-W; Oh, D-Y; Im, S-A; Park, S. R.; Lee, K-W; Song, H. S.; Lee, N-S; Lee, K. H.; Choi, I. S.; Lee, M. H.; Kim, M. A.; Kim, W. H.; Bang, Y-J; Kim, T-Y British Journal of Cancer, Vol.100 No.2, pp.298-304	DOI
2009-03	Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival Kim, J. -S.; Kim, M. -A.; Kim, T. M.; Lee, S. -H.; Kim, D. -W.; Im, S. -A.; Kim, T. -Y.; Kim, W. H.; Yang, H. -K.; Heo, D. S.; Bang, Y. -J.; Lee, K. -U.; Choe, K. -J.; Kim, N. K. British Journal of Cancer, Vol.100 No.5, pp.732-738	DOI
2010-09	Clinicopathologic features and clinical outcomes of gastric cancer that initially presents with disseminated intravascular coagulation: A retrospective study Rhee, Jiyoung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue Journal of Gastroenterology and Hepatology, Vol.25 No.9, pp.1537-1542	DOI
2011-02	Increasing Nodal Ratio is a Poor Prognostic Factor for Survival in Stage III-IV (M0) Gastric Cancer Patients Who Received Curative Surgery Followed by Adjuvant Chemotherapy: A Retrospective Study Kim, Jin-Soo; Kim, Min-A; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Im, Seock-Ah; Kim, Woo Ho; Yang, Han-Kwang; Heo, Dae Seog; Bang, Yung-Jue; Lee, Kuhn-Uk; Kim, Tae-You Japanese Journal of Clinical Oncology, Vol.41 No.2, pp.245-252	DOI
2011-06	Clinicopathologic characteristics of patients with stage III/IV (M 0) advanced gastric cancer, according to HER2 status assessed by immunohistochemistry and fluorescence in situ hybridization Im, Seock-Ah; Kim, Jin Won; Kim, Jin-Soo; Kim, Min A.; Jordan, Bruce; Pickl, Marlene; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk Joon; Kim, Tae-You; Kim, Woo Ho; Yang, Han-Kwang; Bang, Yung-Jue Diagnostic Molecular Pathology, Vol.20 No.2, pp.94-100	DOI
2012-04	The Prognostic Significance of HER2 Positivity for Advanced Gastric Cancer Patients Undergoing First-line Modified FOLFOX-6 Regimen Kim, Jin Won; Im, Seock-Ah; Kim, Miso; Cha, Yongjun; Lee, Kyung-Hun; Keam, Bhumsuk; Kim, Min A.; Han, Sae-Won; Oh, Do-Youn; Kim, Tae-You; Kim, Woo Ho; Bang, Yung-Jue Anticancer Research, Vol.32 No.4, pp.1547-1553
2012-04	NVP-BKM120, a novel PI3K inhibitor, shows synergism with a STAT3 inhibitor in human gastric cancer cells harboring KRAS mutations Park, Eunju; Park, Jinah; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Oh, Do-Youn; Bang, Yung-Jue International Journal of Oncology, Vol.40 No.4, pp.1259-1266	DOI
2014-01	Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker Kim, Jin Won; Im, Seock-Ah; Kim, Min A.; Cho, Hyun Jin; Lee, Dae Won; Lee, Kyung-Hun; Kim, Tae-Yong; Han, Sae-Won; Oh, Do-Youn; Lee, Hyuk-Joon; Kim, Tae-You; Yang, Han-Kwang; Kim, Woo Ho; Bang, Yung-Jue International Journal of Cancer, Vol.134 No.1, pp.72-80	DOI
2015-11	The distinct signatures of VEGF and soluble VEGFR2 increase prognostic implication in gastric cancer Ock, Chan-Young; Nam, Ah-Rong; Bang, Ju-Hee; Kim, Tae-Yong; Lee, Kyung-Hun; Han, Sae-Won; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Oh, Do-Youn American Journal of Cancer Research, Vol.5 No.11, pp.3376-3388
2017-01	Quantitative proteomic analysis of HER2 expression in the selection of gastric cancer patients for trastuzumab treatment An, Eunkyung; Ock, Chan Young; Kim, Tae You; Lee, Kyung Hun; Han, Se Won; Im, Seock Ah; Kim, Tae Yong; Liao, Wei Li; Cecchi, Fabiola; Blackler, Adele; Thyparambil, Sheeno; Kim, W. H.; Burrows, Jon; Hembrough, Todd; Catenacci, Daniel V.T.; Oh, Do Youn; Bang, Yung–Jue Annals of Oncology, Vol.28 No.1, pp.110-115	DOI

1